dc.creatorValenzuela, Vicente
dc.creatorJackson, Kasey L.
dc.creatorSardi, Sergio P.
dc.creatorHetz Flores, Claudio
dc.date.accessioned2019-03-18T12:02:11Z
dc.date.available2019-03-18T12:02:11Z
dc.date.created2019-03-18T12:02:11Z
dc.date.issued2018
dc.identifierMolecular Therapy, Volumen 26, Issue 6, 2018, Pages 1404-1413
dc.identifier15250024
dc.identifier15250016
dc.identifier10.1016/j.ymthe.2018.04.004
dc.identifierhttps://repositorio.uchile.cl/handle/2250/167443
dc.description.abstract© 2018 The American Society of Gene and Cell Therapy Proteostasis alterations are proposed as a transversal hallmark of several pathological conditions, including metabolic disorders, mechanical injury, cardiac malfunction, neurodegeneration, and cancer. Strategies to improve proteostasis aim to reduce the accumulation of specific disease-related misfolded proteins or bolster the endogenous mechanisms to fold and degrade abnormal proteins. Endoplasmic reticulum (ER) stress is a common pathological signature of a variety of diseases, which engages the unfolded protein response (UPR) as a cellular reaction to mitigate ER stress. Pharmacological modulation of the UPR is challenging considering the physiological importance of the pathway in various organs. However, local targeting of ER stress responses in the affected tissue using gene therapy is emerging as a possible solution to overcome side effects. The delivery of ER chaperones or active UPR components using adeno-associated virus (A
dc.languageen
dc.publisherCell Press
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceMolecular Therapy
dc.subjectAAV
dc.subjectdiabetes
dc.subjectER stress
dc.subjectgene therapy
dc.subjectneurodegeneration
dc.subjectprotein misfolding
dc.subjectUPR
dc.titleGene Therapy Strategies to Restore ER Proteostasis in Disease
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución